DEVA:IST
Deva Holding AS
79,20 TRY
0,00%
(0,00) 1D
14 հոկ, 18:09:13 GMT+3 · TRY
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for DEVA...
Mkt. cap
15,84 մլրդ
Avg. vol.
613,11 հզր
Volume
0,00
52-wk high
109,30 TRY
52-wk low
57,50 TRY
EPS
-4,21 TRY
Shares outstanding
200,02 մլն
No. of employees
3 հզր
Mkt. cap
15,84 մլրդ
Avg. vol.
613,11 հզր
Volume
0,00
52-wk high
109,30 TRY
52-wk low
57,50 TRY
EPS
-4,21 TRY
Shares outstanding
200,02 մլն
No. of employees
3 հզր
News stories
From web sources and news partners
Simply Wall Street
·
2 րոպե առաջ
Does Early Pancreatic Recovery Change The Bull Case For Vertex Pharmaceuticals (VRTX)?
MarketBeat
·
1 րոպե առաջ
The Hackett Group (NASDAQ:HCKT) Stock Crosses Above Two Hundred Day Moving Average - What's Next?
Northwest Arkansas Democrat-Gazette
·
8 րոպե առաջ
Stocks see worst day since July as inflation increases
Profile
DEVA Holding A.Ş. is a Turkish pharmaceutical company operating since 1958. Its principal activities include the development, manufacture and marketing of human pharmaceuticals and active pharmaceutical ingredients. The company also operates in veterinary medicines, cologne, medical ampoules and food supplements.
A majority stake in the company was acquired by EastPharma in 2006. DEVA Holding is listed on Borsa Istanbul, and its chairman and chief executive officer is Philipp Haas.
As of 2025, the company had more than 675 products across 15 therapeutic areas. According to IQVIA data cited in its annual report, DEVA ranked third in the Turkish pharmaceutical market by unit sales in 2025, with a market share of 4.5%. Wikipedia
About Deva Holding AS